Table 5.
Size of largest polyp | |||||
---|---|---|---|---|---|
Ages | None (%) | <6 mm (diminutive) (%)a | 6–9 mm (small) (%) | 10+ mm (large) (%) | All (%) |
Male | |||||
50–54 | 48.4 | 36.9 | 8.6 | 6.1 | 100 |
55–59 | 44.4 | 38.0 | 10.3 | 7.3 | 100 |
60–64 | 38.7 | 42.1 | 10.6 | 8.6 | 100 |
65–69 | 41.0 | 37.6 | 11.8 | 9.6 | 100 |
70–74 | 40.3 | 38.7 | 11.3 | 9.7 | 100 |
75–79 | 39.3 | 38.4 | 12.0 | 10.3 | 100 |
80–84 | 44.0 | 33.4 | 11.6 | 11.0 | 100 |
Female | |||||
50–54 | 50.4 | 39.2 | 6.4 | 4.0 | 100 |
55–59 | 47.4 | 40.6 | 7.4 | 4.6 | 100 |
60–64 | 48.1 | 39.4 | 7.3 | 5.2 | 100 |
65–69 | 50.9 | 35.2 | 8.1 | 5.8 | 100 |
70–74 | 49.4 | 35.7 | 8.5 | 6.4 | 100 |
75–79 | 48.9 | 34.6 | 9.4 | 7.1 | 100 |
80–84 | 49.4 | 34.6 | 8.7 | 7.3 | 100 |
aNot used for the CTC analysis other than for scenario 9; isolated diminutive polyps identified by CTC are not reported and as a finding has the same effect as no polyps
Source: Authors’ analysis of published literature and 2013 Medicare 5% Sample data. See Appendix in supplementary material